Predictive Value of Single Nucleotide Polymorphisms of ERCC1, XPA, XPC, XPD and XPG Genes, Involved in NER Mechanism in Patients with Advanced NSCLC Treated with Cisplatin and Gemcitabine

The combination of cisplatin and gemcitabine is still one of the most frequently used first-line chemotherapy scheme in patients with advanced non-small cell lung cancer (NSCLC), in which tyrosine kinase inhibitors (TKIs) cannot be administered. Unfortunately, more than half of the patients have no...

Descripción completa

Detalles Bibliográficos
Autores principales: Mlak, Radosław, Krawczyk, Paweł, Homa-Mlak, Iwona, Powrózek, Tomasz, Ciesielka, Marzanna, Kozioł, Piotr, Milanowski, Janusz, Małecka-Massalska, Teresa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614130/
https://www.ncbi.nlm.nih.gov/pubmed/30066234
http://dx.doi.org/10.1007/s12253-018-0459-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6614130/
https://www.ncbi.nlm.nih.gov/pubmed/30066234
http://dx.doi.org/10.1007/s12253-018-0459-8

Ejemplares similares